Sarsys Past Earnings Performance

Past criteria checks 0/6

Sarsys's earnings have been declining at an average annual rate of -40.2%, while the Aerospace & Defense industry saw earnings growing at 19.1% annually. Revenues have been declining at an average rate of 19.3% per year.

Key information

-40.2%

Earnings growth rate

-39.6%

EPS growth rate

Aerospace & Defense Industry Growth14.9%
Revenue growth rate-19.3%
Return on equityn/a
Net Margin-35.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Does SARSYS-ASFT (NGM:SARS) Have A Healthy Balance Sheet?

Apr 21
Does SARSYS-ASFT (NGM:SARS) Have A Healthy Balance Sheet?

SARSYS-ASFT AB (publ)'s (NGM:SARS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Mar 09
SARSYS-ASFT AB (publ)'s (NGM:SARS) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?

Revenue & Expenses Breakdown

How Sarsys makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NGM:SARS Revenue, expenses and earnings (SEK Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2441-15320
30 Jun 2441-12310
31 Mar 2444-8290
31 Dec 2344-6260
30 Sep 2342-5250
30 Jun 2337-8260
31 Mar 2336-7280
31 Dec 2237-10300
30 Sep 2235-10320
30 Jun 2235-9320
31 Mar 2236-11310
31 Dec 2135-13310
30 Sep 2147-10310
30 Jun 2160-2310
31 Mar 2160-2320
31 Dec 20680340
30 Sep 20750360
30 Jun 2074-4370
31 Mar 20870380
31 Dec 19924380
30 Sep 19824360
30 Jun 19784370
31 Mar 19670340
31 Dec 1859-5310
30 Sep 1851-5260
30 Jun 1843-5210
31 Mar 1838-2170
31 Dec 17331130
31 Dec 1617170
31 Dec 1514060
31 Dec 1418150

Quality Earnings: SARS is currently unprofitable.

Growing Profit Margin: SARS is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: SARS is unprofitable, and losses have increased over the past 5 years at a rate of 40.2% per year.

Accelerating Growth: Unable to compare SARS's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: SARS is unprofitable, making it difficult to compare its past year earnings growth to the Aerospace & Defense industry (31.7%).


Return on Equity

High ROE: SARS's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/24 21:42
End of Day Share Price 2025/02/24 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Sarsys AB is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.